- Home
- TAOP vs KTTA Comparison
TAOP vs KTTA Comparison
Compare TAOP & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- KTTA
- Stock Information
- Founded
- TAOP 1993
- KTTA 2020
- Country
- TAOP China
- KTTA United States
- Employees
- TAOP N/A
- KTTA N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- TAOP Technology
- KTTA Health Care
- Exchange
- TAOP Nasdaq
- KTTA Nasdaq
- Market Cap
- TAOP 2.8M
- KTTA 3.2M
- IPO Year
- TAOP N/A
- KTTA 2021
- Fundamental
- Price
- TAOP $0.32
- KTTA $2.48
- Analyst Decision
- TAOP
- KTTA
- Analyst Count
- TAOP 0
- KTTA 0
- Target Price
- TAOP N/A
- KTTA N/A
- AVG Volume (30 Days)
- TAOP 9.3M
- KTTA 43.9K
- Earning Date
- TAOP 09-05-2024
- KTTA 11-13-2024
- Dividend Yield
- TAOP N/A
- KTTA N/A
- EPS Growth
- TAOP N/A
- KTTA N/A
- EPS
- TAOP 0.50
- KTTA N/A
- Revenue
- TAOP $42,636,173.00
- KTTA N/A
- Revenue This Year
- TAOP N/A
- KTTA N/A
- Revenue Next Year
- TAOP N/A
- KTTA N/A
- P/E Ratio
- TAOP $0.51
- KTTA N/A
- Revenue Growth
- TAOP 37.49
- KTTA N/A
- 52 Week Low
- TAOP $0.29
- KTTA $2.20
- 52 Week High
- TAOP $1.98
- KTTA $9.25
- Technical
- Relative Strength Index (RSI)
- TAOP 40.19
- KTTA 38.84
- Support Level
- TAOP $0.29
- KTTA $2.20
- Resistance Level
- TAOP $0.40
- KTTA $2.61
- Average True Range (ATR)
- TAOP 0.05
- KTTA 0.28
- MACD
- TAOP -0.01
- KTTA -0.03
- Stochastic Oscillator
- TAOP 21.33
- KTTA 24.35
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.